Cataplexy

·MeSH: Cataplexy

6 drugs in development·6 companies·1 clinical trial

Drug Pipeline by Phase

Approved(6)

Drug	Company
LUMRYZ	Alkermes plc. (ALKS)
pitolisant	Viatris Inc (VTRS)
pitolisant	Impax Laboratories, LLC (IPXL)
sodium oxybate	Nascent Biotech Inc. (NBIO)
WAKIX	Harmony Biosciences Holdings, Inc. (HRMY)
xyrem	Jazz Pharmaceuticals plc (JAZZ)

BioSniper tracks 6 drugs in development for Cataplexy across 6 companies.

There are 1 clinical trial targeting Cataplexy tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.